Cargando…
Dolutegravir Plus Abacavir/Lamivudine for the Treatment of HIV-1 Infection in Antiretroviral Therapy-Naive Patients: Week 96 and Week 144 Results From the SINGLE Randomized Clinical Trial: Erratum
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
JAIDS Journal of Acquired Immune Deficiency Syndromes
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4819527/ http://dx.doi.org/10.1097/QAI.0000000000000916 |
| _version_ | 1782425219458138112 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4819527 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2016 |
| publisher | JAIDS Journal of Acquired Immune Deficiency Syndromes |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-48195272016-04-21 Dolutegravir Plus Abacavir/Lamivudine for the Treatment of HIV-1 Infection in Antiretroviral Therapy-Naive Patients: Week 96 and Week 144 Results From the SINGLE Randomized Clinical Trial: Erratum J Acquir Immune Defic Syndr Erratum JAIDS Journal of Acquired Immune Deficiency Syndromes 2016-01-01 2015-12-11 /pmc/articles/PMC4819527/ http://dx.doi.org/10.1097/QAI.0000000000000916 Text en Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved. |
| spellingShingle | Erratum Dolutegravir Plus Abacavir/Lamivudine for the Treatment of HIV-1 Infection in Antiretroviral Therapy-Naive Patients: Week 96 and Week 144 Results From the SINGLE Randomized Clinical Trial: Erratum |
| title | Dolutegravir Plus Abacavir/Lamivudine for the Treatment of HIV-1 Infection in Antiretroviral Therapy-Naive Patients: Week 96 and Week 144 Results From the SINGLE Randomized Clinical Trial: Erratum |
| title_full | Dolutegravir Plus Abacavir/Lamivudine for the Treatment of HIV-1 Infection in Antiretroviral Therapy-Naive Patients: Week 96 and Week 144 Results From the SINGLE Randomized Clinical Trial: Erratum |
| title_fullStr | Dolutegravir Plus Abacavir/Lamivudine for the Treatment of HIV-1 Infection in Antiretroviral Therapy-Naive Patients: Week 96 and Week 144 Results From the SINGLE Randomized Clinical Trial: Erratum |
| title_full_unstemmed | Dolutegravir Plus Abacavir/Lamivudine for the Treatment of HIV-1 Infection in Antiretroviral Therapy-Naive Patients: Week 96 and Week 144 Results From the SINGLE Randomized Clinical Trial: Erratum |
| title_short | Dolutegravir Plus Abacavir/Lamivudine for the Treatment of HIV-1 Infection in Antiretroviral Therapy-Naive Patients: Week 96 and Week 144 Results From the SINGLE Randomized Clinical Trial: Erratum |
| title_sort | dolutegravir plus abacavir/lamivudine for the treatment of hiv-1 infection in antiretroviral therapy-naive patients: week 96 and week 144 results from the single randomized clinical trial: erratum |
| topic | Erratum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4819527/ http://dx.doi.org/10.1097/QAI.0000000000000916 |